FDA clears QuidelOrtho Savanna platform, HSV 1+2/VZV assay

Create PDF

The platform enables users to analyze up to 12 pathogens or targets, plus up to four controls, from a single test run in about 25 minutes, depending on the assay. Once the test panel cartridge is inserted into the platform, the instrument performs sample and reagent preparation, nucleic acid extraction and amplification, real-time detection of RNA or DNA target sequence, and qualitative or quantitative result interpretation from a variety of sample types.